6The American multichannel pioneers
The multichannel cochlear implant has no single inventor. While William House pursued his single-channel device and Graeme Clark built the Australian multichannel implant, several American groups were independently laying the scientific and engineering groundwork for stimulating the cochlea at many points at once. Blair Simmons at Stanford had shown as early as 1964 that different electrodes evoke different pitches; the UCSF group of Michelson and Merzenich developed a multichannel design whose descendants are still sold today; and the Utah group's Ineraid became a crucial research platform for the speech-coding work that would transform the field. This module gives these parallel threads their due.
FMany hands on the problem
It is tempting to tell the implant's story as a single line from one inventor, but the reality is a convergence of independent efforts. Through the 1960s and 1970s, separated by oceans and by rivalries, different groups attacked different parts of the problem — and the modern device is a synthesis of what they each established.
CSimmons at Stanford
Blair Simmons performed some of the most important early human work. In 1964 he stimulated the auditory nerve directly through the modiolus using multiple electrodes, and showed in careful psychophysical studies that stimulating different sites produced different pitch sensations. This was the first solid human evidence for the idea on which all multichannel implants rest: that the place of stimulation can carry frequency information.[1966]
CMichelson & Merzenich at UCSF
At the University of California, San Francisco, Robin Michelson and the neuroscientist Michael Merzenich developed an intracochlear multichannelsystem through the 1970s. Merzenich's deep grounding in cortical map plasticity (Chapter 3) informed the design. The UCSF approach matured into the Clarion device, whose corporate lineage became Advanced Bionics — one of the major manufacturers still in the market.
CIneraid and the research platform
A group in Utah (including Donald Eddington) built the Ineraid (Symbion) device, which used a percutaneous connector — a plug through the skin giving direct access to each electrode. As a product the percutaneous design was ultimately superseded by transcutaneous devices, but as a research platform that direct access was invaluable: it let investigators drive individual electrodes precisely, and it was on Ineraid users that some of the decisive speech-coding experiments were later performed (Module 9).
FTWhy the parallel effort mattered
The parallelism was not wasteful duplication. Different groups proved different essential points — Simmons that place encodes pitch, UCSF that a manufacturable multichannel device could be built, Utah that a research platform could expose how best to drive it. The cochlear implant that emerged is genuinely a collective achievement, and the manufacturers competing today descend from these distinct lineages. The most famous multichannel program, however, grew up an ocean away, around one determined surgeon in Melbourne.
We turn to him next — Graeme Clark and the Nucleus implant (Module 7).
What made the percutaneous design valuable despite its drawback?
What did Blair Simmons demonstrate at Stanford in the 1960s?
Which modern manufacturer descends from the UCSF (Michelson & Merzenich) lineage?